Jan 30, 2013

Come hear about our projects at the Contact meeting


Head of the Genomics Core Facility Leonardo Meza-Zepeda will at the NBS Contact meeting present two large projects on Personalized Cancer Medicine that the Core Facility is part of.

The projects Personalized Cancer Medicine and Lung cancer Pilot Project will be presented by Leonardo Meza-Zepeda in two minisymposia at the 2013 NBS Contact meeting at Lillehammer. The first presentation will be in Minisymposia 3 at 5 pm, the second in Minisymposia 1 at 6 pm, both on Thursday January 31.

Personalized Cancer medicine is a prioritized area for the National Health Service in Norway, and the Personalized Cancer Medicine consortium have recieved two major grants to among other objectives provide a national network for implementation of personalised cancer medicine in Norway.

 
 
 
 


News

Sep 15, 2018

The Genomics Core Facility has recently installed a NanoString nCounter system. The nCounter utilizes a novel digital barcode technology for direct multiplexed measurement of analytes and offers high levels of precision and sensitivity. This technology allows the analysis of expression of up to 800 mRNAs, miRNAs, DNA regions, or proteins simultaneously, using predesigned assays, as well as custom solutions. 

May 5, 2018
The Genomics Core Facility has recently acquired new instrumentation, the ChromiumTM(10X Genomics) and RhapsodyTM(BD Genomics) enabling Single Cell Sequencing and sequencing of Artificial Long Reads.


Contact Information:

Genomics@rr-research.no

Unit Leader Core Facility
Susanne Lorenz, PhD

Susanne.Lorenz@rr-research.no

Head of Core Facility
Leonardo A. Meza-Zepeda, Dr. philos.

Leonardo.A.Meza-Zepeda@rr-research.no

Visiting address:

Genomics Core Facility (Room 3-F8-04)
Department of Core facilities
Institute for Cancer Research
New OCCI-building 
 
Norwegian Radium Hospital 
Ullernchaussen 66, Lamell 3, 2B 
NO-0379 Oslo, NORWAY

+47 - 9183 2772 Laboratory
+47 - 9183 3425 Office

................................................................

................................................................